This article needs additional citations for verification. (May 2014) |
CLaCS (Cryo-Laser and Cryo-Sclerotherapy) is a treatment for leg vein lesions by combining transdermal laser effect and injection sclerotherapy, all under skin cooling (Cryo - cold air blown onto the skin at -20C).[1][2][3] The laser causes a selective photothermolysis damaging the vein wall. The vein's lumen gets smaller. On a second procedure, sclerosing agent is injected where the vein is still open. This combination can be used treat veins that could be treated by phleboectomy or foam sclerotherapy - more invasive options. To improve results, CLaCS can be guided by Augmented Reality[4] (near-infrared vein finder).[5]
CLaCS was created by Dr. Roberto Kasuo Miyake (also knowns as Kasuo Miyake), in 1999, to adhere to patients' requests for treatment that did not require hospitalizations.[3]
References
edit- ^ "Cryo-laser and cryo-sclerotherapy guided by augmented reality for telangiectasias, feeder, and small varicose vein treatment–The CLaCS technique white paper report". scholar.google.com. Retrieved 2024-07-10.
- ^ Miyake, Roberto Kasuo; Chi, Yung-Wei; Franklin, Ian J.; Gianesini, Sergio. "State of the art on cryo-laser cryo-sclerotherapy in lower limb venous aesthetic treatment". Journal of Vascular Surgery. Venous and Lymphatic Disorders. 8 (5): 893–895. doi:10.1016/j.jvsv.2020.01.003. ISSN 2213-3348. PMID 32179040.
- ^ a b Miyake, Hiroshi; Miyake, Kasuo; Duarte, Flávio; Kikuchi, Rodrigo (2008). "Pequenas Varizes e Telangiectasias" [Small Varicose Veins and Telangiectasias]. Doenças Vasculares Periféricas (in Portuguese). 2 (4 ed.). Rio de Janeiro, RJ: Guanabara Koogan S.A.: 1769–1795. ISBN 9788527714600.
- ^ "Reality, only better, December 8th". The Economist. ISSN 0013-0613. Retrieved 2024-07-10.
- ^ Miyake, RK; Zeman, HD; Duarte, FH; Kikuchi, R; Ramacciotti, E; Lovhoiden, G; Vrancken, C (2014-01-24). "Vein imaging: a new method of near infrared imaging, where a processed image is projected onto the skin for the enhancement of vein treatment". Dermatol Surg. 32 (8): 1031–8. doi:10.1111/j.1524-4725.2006.32226.x. PMID 16918565. S2CID 8872471.